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Coronavirus encodes an extensively phosphorylated and highly basic nucleocapsid (N) protein. Previous
studies have identiﬁed Ser190, Ser192, Thr378 and Ser379 as the phosphorylation sites for coronavirus
infectious bronchitis virus (IBV) N protein. In this study, we show that phosphorylation at Thr378 and
Ser379 sites is dependent on the ataxia-telangiectasia mutated (ATM) and Rad3-related (ATR), a kinase
activated during IBV replication. Introduction of Ala substitutions at these two sites individually, in
combination of the two and together with other two sites (Ser190 and Ser192) into an infectious IBV
clone did not affect recovery of the recombinant viruses containing the mutations. A mutant virus (rIBV-
Nm4) carrying the four Ala substitutions grew at a similar, if not better, growth rate as wild type virus.
This study reveals a cellular kinase responsible for phosphorylation of a coronavirus N protein at two
positions and the functional consequence of this modiﬁcation on coronavirus replication.
& 2013 Elsevier Inc. All rights reserved.Introduction
Coronavirus is an enveloped virus with a single strand,
positive-sense RNA genome of 27–30 kb length. In cells infected
with coronavirus, a 3′-coterminal nested set of 6–9 mRNAs species,
including the genome-length mRNA (mRNA1) and 5–8 subge-
nomic mRNA species (mRNA2–9), is expressed. The genome-
length mRNA1 encodes two overlapping replicase proteins in the
form of polyproteins 1a and 1ab, which are processed by virus-
encoded proteinases into at least 15 putative nonstructural pro-
teins (NSP1–NSP16) (Fang et al., 2008, 2010). The four structural
proteins, spike (S), envelope (E), membrane (M) and nucleocapsid
(N), are encoded by subgenomic mRNAs. In addition, several
putative nonstructural proteins, such as 3a, 3b, 6, 7a, 7b, 8a, 8b,
9b, are also encoded by subgenomic mRNAs (Snijder et al., 2003;
Thiel et al., 2003).
Coronavirus N protein contains multiple functional domains.
Sequence comparisons and structural studies have identiﬁed three
main structural domains, although their primary sequence con-
servation is low (Lai and Cavanagh, 1997; Li et al., 2005). Of this
the middle domain is an RNA-binding domain, capable of bindingll rights reserved.both coronavirus- and non-coronavirus-derived RNA sequences
in vitro (Stohlman et al., 1988; Tan et al., 2012; Zhou et al., 1996).
The motifs for ribosome binding and nucleolar localization signals
have been assigned to domain III (Wurm et al., 2001). More
recently, Chang et al. (2009) proposed that all coronavirus N
proteins may share a similar modular organization. In cells
expressing the N protein, it localizes either to the cytoplasm alone
or to the cytoplasm and nucleolus (Hiscox et al., 2001). This
nucleolar localization has been shown to be a common feature
of the coronavirus family (Wurm et al., 2001). The prime function
of the protein is to associate with the genomic RNA to form a
ribonucleoprotein complex (RNP) and viral core (Davies et al.,
1981; Escors et al., 2001; Narayana et al., 2000; Riso et al., 1996).
The protein may also play an important role in the replication of
the genomic RNA (Chang and Brian, 1996), and in the transcription
and translation of subgenomic RNAs (sgRNA) (Almazán et al.,
2004; Baric et al., 1988; Stohlman et al., 1988; Tahara et al.,
1994; Zúñiga et al., 2010). In addition, N protein might inhibit
host cell proliferation or delay cell growth, possibly by disrupting
cytokinesis (Chen et al., 2002; Wurm et al., 2001). It can also
stimulate strong humoral and cellular immune response, making it
a potential vaccine candidate (Kim et al., 2004).
Coronaviruse N protein is an extensively phosphorylated and
highly basic protein. It varies from 377 to 455 amino acids in
length and has high serine content (7–11%) as potential targets
for phosphorylation. This protein contains several basic amino
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RNA-binding motifs, and a serine/arginine (S/R) rich motif (Li et al.,
2005, Fan et al., 2005; Tan et al., 2006). Biochemical characteriza-
tion and mutagenesis studies demonstrated that coronavirus N
protein was also posttranslationally modiﬁed by covalent attach-
ment to the small ubiquitin-like modiﬁer (SUMO). Sumoylation
may play a role in the self-association and homo-oligomerization
of the N protein, and its interference of host cell division (Li et al.,
2005).
Infectious Bronchitis Virus (IBV), a prototype coronavirus,
is the etiological agent of infectious bronchitis, which impairs
the respiratory and urogenital tracts of chickens (Cavanagh, 2007).
Similar to other coronaviruses, IBV N protein is heavily phosphory-
lated. By using mass spectroscopic analysis, two conserved amino
acid clusters, Ser190Ser192 and Thr378Ser379, in IBV N protein
were identiﬁed as the two regions for phosphorylation (Chen
et al., 2005). Subsequently, a total of six residues (Ser162, Ser170,
Thr177, Ser389, Ser424 and Thr428) were identiﬁed as phosphor-
ylation sites for mouse hepatitis virus (MHV) A59 N protein (White
et al., 2007), and four phosphoserines at positions 9, 156, 254 and
256 were identiﬁed in transmissible gastroenteritis virus (TGEV) N
protein (Calvo et al., 2005). In addition, the host cell kinase
(s) responsible for phosphorylation of coronavirus N protein is
beginning to emerge. One example is glycogen synthase kinase-3,
which was shown to be involved in regulation of the phosphor-
ylation of severe acute respiratory syndrome coronavirus (SARS-
CoV) N protein (Wu et al., 2009). Current evidence suggests that
phosphorylation may play important roles in regulation of the
functions of coronavirus N protein. These included regulation of its
subcellular location, viral RNA transcription, particle assembly,
immunoreactivity and speciﬁcity (Calvo et al., 2005; Jayaram
et al., 2005; Shin et al., 2007; Surjit et al., 2005; Spencer et al.,
2008). However, the functional relevance of N protein phosphor-
ylation has not been rigorously tested in the context of virus-
infected cells using an infectious clone system, and host cell
kinases responsible for phosphorylation of other coronavirus N
proteins are not reported.
IBV infection perturbs cell cycle progression and arrests cell at
the S and G2/M phases (Li et al., 2007; Wilson and Rangasamy,
2001; Wurm et al., 2001). More recently, IBV infection was shown
to induce DNA damage response and activation of the ataxia-
telangiectasia mutated (ATM) and Rad3-related (ATR) kinase/
checkpoint kinase-1 (Chk1) pathway partly through interaction
between coronavirus nsp13 and DNA polymerase delta (Pol δ) (Xu
et al., 2011). In this study, we show that phosphorylation at the
Thr378 and Ser379 sites is dependent on ATR, a kinase activated
during IBV replication. Introduction of Ala substitutions at these
two sites individually, in combination of the two, and together
with the other two sites (Ser190 and Ser192), into an infectious
IBV clone did not affect the recovery of recombinant viruses
containing the mutations. A mutant virus (rIBV-Nm4) carrying
Ala substitutions at all the four previously identiﬁed sites grew at a
similar, if not better, growth rate as wild type virus. This study
reveals a cellular kinase responsible for phosphorylation of a
coronavirus N protein at two sites and the functional consequence
of this modiﬁcation on coronavirus replication in virus-
infected cells. α
-actin
Fig. 1. Detection of phosphorylated IBV N protein by Western blot analysis with
anti-phosphor Chk1(S317) antibodies. H1299 cells were infected with live IBV
(IBV) or UV inactivated IBV (IBV-UV) at a multiplicity of infection of approximately
2. The mock-treated cells were also included as a control. At 4, 8 and 12 h post-
infection, cells were harvested and total lysates were subjected to immunoblotting
assay. The levels of phosphor-Chk1 (pChk1(S317)), total Chk1, actin and IBV N were
determined with appropriate antibodies. Actin serves as a loading control, and IBV
N protein as a marker of IBV infection.Results
Speciﬁc recognition of IBV N protein by phosphorylated Chk1
antibodies in IBV-infected cells
In a previous study, we showed the phosphorylation of a
number of ATR-speciﬁc substrates, including Chk1, the beststudied ATR substrate on Ser317 and Ser345, and replication
protein A2 (RPA2), a component of the heterotrimeric RPA com-
plex, on Ser4/8 in IBV-infected cells (Xu et al., 2011). The speciﬁc
residues for the ATM kinase activity including Chk2 on Thr68 and
ATM on Ser1981, however, were not detected in the same infected
cells, demonstrating the activation of the ATR–Chk1 pathway
during IBV infection (Xu et al., 2011). During this study, we noted
that, when cells were infected with IBV at high multiplicity of
infection and an excess amount of samples was loaded, a batch of
pChk1-speciﬁc antibodies was also able to detect clearly a band
migrating slightly more rapidly than pChk1 in IBV-infected cells,
but not in cells infected with the ultraviolet (UV)-inactivated IBV at
8 and 12 h post-infection (Fig. 1). It should be pointed out that this
observation was not consistently made when pChk1-speciﬁc
antibodies from different sources were used. It was also noted
that apparently more pChk1 was detected in cells treated with
UV-inactivated IBV (Fig. 1). This increased detection of pChk1 may
represent cellular contamination from the inoculums, as the virus
stocks used for UV irradiation were prepared by freezing/thawing
the infected cells and were not puriﬁed.
Re-probing of the same membrane with antibodies against IBV
N protein detected the N protein at the exact position (Fig. 1). This
result suggests that the protein band detected by anti-pChk1 may
be a phosphorylated form of the IBV N protein.
ATR-dependent phosphorylation of IBV N protein
A series of experiments was then carried out to conﬁrm if this
indeed represents a phosphorylated form of IBV N protein and if
ATR is responsible for its phosphorylation. First, cells infected with
IBV were analyzed by Western blot with antibodies against IBV N
protein and ATM/ATR substrates. As shown in Fig. 2a, the full-
length 48-kDa IBV N protein and several smaller bands, represent-
ing either premature or cleavage products derived from N protein
(Li et al., 2005), were detected by Western blot with anti-IBV N
antibodies. The 48-kDa band was also detected efﬁciently by the
anti-ATM/ATR substrate antibodies (Fig. 2a). In addition, a back-
ground band with unknown identity was also detected from both
mock- and IBV-infected cells by this antibody (Fig. 2a).
The involvement of ATR in the phosphorylation of IBV N protein
was then analyzed by addition of 10 and 15 μM of Schisandrin B
(SchB), a speciﬁc ATR inhibitor functioning in IBV-infected cells as
demonstrated in a previous study (Xu et al., 2011), to IBV-infected
Fig. 2. Phosphorylation of IBV N protein by the activated ATR. (a) Detection of phosphorylated IBV N protein by Western blot analysis with anti-ATR/ATM substrate
antibodies. H1299 cells were infected with IBV (wt) at a multiplicity of infection of approximately 1. The mock-treated cells were also included as a control. At 24 hours post-
infection, cells were harvested and total lysates were subjected to immunoblotting assay. The levels of phosphorylated and total IBV N were determined with appropriate
antibodies. (b) Analysis of the growth kinetics of wild type and rIBV-fN viruses. Monolayers of H1299 cells were infected with the viruses and harvested at 0, 4, 8, 16, 24 and
32 h post-inoculation. Viral stocks were prepared by freezing/thawing of the cells three times and TCID50 of each viral stock was determined by infecting ﬁve wells of Vero
cells on 96-well plates in triplicate with 10-fold serial dilution of each viral stock. (c) Inhibition of ATR-dependent phosphorylation of IBV N protein by SchB in IBV-infected
cells. H1299 cells were infected with rIBV-fN at a multiplicity of infection of approximately 1. At 4 h post-infection, 10 and 15 μM of SchB were added to the cultured media.
Cells were harvested at 24 h post-infection and total lysates were subjected to immunoblotting assay. The levels of phosphorylated and total IBV N were determined with
anti-Flag and anti-ATR/ATR substrates antibodies, respectively. Tubulin was included as a loading control. (d) Inhibition of ATR-dependent phosphorylation of IBV N protein
by SchB in cells over-expressing the protein. H1299 cells were transfected with IBN N. At 22 h post-transfection, 10 μM of SchB was added to the culture media and cells were
subjected to UV irradiation. Cells were harvested at 24 h post-infection and total lysates were subjected to immunoblotting assay. The levels of phosphorylated and total IBV
N were determined with anti-IBV N and anti-ATR/ATR substrates antibodies, respectively. Tubulin was included as a loading control.
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IBV N with an unrelated antibody, a recombinant IBV (rIBV-fN) with a
Flag tag added to the N-terminus of the IBV N protein was
constructed and used in this study. The recombinant virus showed
very similar growth kinetics as wild type IBV (Fig. 2b). The cells were
harvested at 24 h post-infection and analyzed by Western blot.
As observed in our previous study (Xu et al., 2011), SchB exhibited
a certain level of inhibitory effect on IBV replication. IBV N protein
was reduced to 78% and 55% when 10 and 15 μM, respectively, of
SchB were added, as revealed by Western blot using anti-Flag
antibodies and densitometry analyses (Fig. 2c). Probing of the same
membrane with antibodies against ATM/ATR substrates detected
much less phosphorylated N protein in the presence of SchB
(Fig. 2c). Quantiﬁcation of the band intensities by densitometry after
normalizing to the total N protein showed that the ATR-dependent
phosphorylation of N protein was reduced to 47% and 2% after
addition of 10 and 15 μM of SchB, respectively (Fig. 2c).
The phosphorylation of IBV N protein by ATR was then
analyzed in cells overexpressing the N protein. Cells transfected
with IBV N construct were subjected to UV irradiation at 22 h post-
transfection in the presence or absence of 10 μM of SchB. Western
blot analysis with antibodies against IBN N and ATM/ATR sub-
strates showed that signiﬁcantly less phosphorylated IBV N pro-
tein was detected in the UV-irradiated, transfected cells in the
presence of 10 μM of SchB (Fig. 2d). In the absence of 10 μM of
SchB, a 2.8-fold increase of the ATR-dependent phosphoryla-
tion of N protein was detected in the transfected cells afterUV-irradiation, compared to that in the cells without UV-irradiation
(Fig. 2d). In the presence of 10 μM of SchB, a 1.5-fold increase of the
ATR-dependent phosphorylation of N protein was detected by the
same comparison (Fig. 2d). These results would lend more support
to the conclusion that ATR is one of the kinases responsible for
phosphorylation of IBV N protein.
Construction and recovery of recombinant IBV carrying Ala
substitutions at six predicted and previously identiﬁed
phosphorylation sites on IBV N protein
To systematically map the ATR-dependent phosphorylation of IBV
N protein, Ala substitutions at the four previously identiﬁed sites
(Ser190, Ser192, Thr378 and Ser379) as well as two potential new
sites (Ser65 and Thr109) predicted to be ATR substrates (Fig. 3a) were
carried out. The Ala substitutions were then introduced into an IBV
infectious clone either individually, or in combination of two, four,
ﬁve or six, and nine recombinant IBVs were recovered from these
constructs (Fig. 3a). All the nine mutant viruses were passaged in
cells up to eight passages and their genetic stability was determined
by nucleotide sequencing of the entire N protein-coding region. The
sequencing results conﬁrmed that the Ala substitutions were stably
maintained in all the mutant viruses, and no additional mutations
were introduced into the N protein during passaging. The growth
properties of the recombinant viruses (passage 8) were then deter-
mined. As shown in Fig. 3b, very similar growth kinetics was found
between wild type IBV and the mutant viruses. One notable
S. Fang et al. / Virology 444 (2013) 225–232228difference was that all mutant viruses reached their peak titers at
32 h post-infection, while wild type virus reached the peak titer at
24 h post-infection (Fig. 3b).
Mapping of the ATR-dependent phosphorylation sites on IBV N
protein by Ala substitutions
Wild type and seven mutant viruses (Nm1–7, passage 3) were
ﬁrst used to infect H1299 cells. Total cell lysates were preparedFig. 3. Construction and recovery of mutant IBV carrying Ala substitutions at
the predicted and previously identiﬁed phosphorylation sites on IBV N protein.
(a) Diagram showing the positions of the four previously identiﬁed phosphoryla-
tion sites and two additional putative sites for ATR on IBV N protein. The Ala
substitutions in each mutant construct are shown. (b) Analysis of the growth
kinetics of wild type and the nine mutant viruses. Monolayers of H1299 cells were
infected with the viruses and harvested at 0, 4, 12, 24 and 32 h post-infection. Viral
stocks were prepared by freezing/thawing of the cells three times and TCID50 of
each viral stock was determined by infecting ﬁve wells of Vero cells on 96-well
plates with 10-fold serial dilution of each viral stock.
Fig. 4. Mapping of the ATR-dependent phosphorylation sites on IBV N protein. (a)
protein. H1299 cells were infected with wild type and seven mutant IBV (Nm1–Nm7)
included as a control. At 24 h post-infection, cells were harvested and total lysates wer
and total IBV N were determined with anti-IBV N, ATM/ATR substrates and pChk1-speci
effects of Ala substitutions on the ATR-dependent phosphorylation of IBV N protein. H
multiplicity of infection of approximately 1. The mock-treated cells were also included
subjected to immunoblotting assay. The levels of ATR-dependent phosphorylated and tot
respectively. Actin was included as a loading control.and analyzed by Western blot with antibodies against ATM/ATR
substrates. The results showed that the ATR-dependent phosphor-
ylation of N protein was detected only in cells infected with wild
type, Nm1 and Nm2 mutant viruses (Fig. 4a). The same band was
not detected in cells infected with other ﬁve mutant viruses
(Nm3–Nm7) (Fig. 4a). As all these ﬁve mutant viruses contain
Ala substitutions at Thr378 and Ser379 positions, it suggests that
phosphorylation of IBV N protein at these two sites is ATR-
dependent. Re-probing of the same membrane with pChk1-
speciﬁc antibodies detected a much reduced amount of the
phosphorylated N protein in cells infected with Nm4 mutant virus,
and moderately reduced amounts of the phosphorylated N protein
in cells infected with Nm3, Nm5, Nm6 and Nm7 mutant viruses,
respectively (Fig. 4a).
The additional two mutant viruses, Nm8 and Nm9 containing the
Ala substitutions at Thr378 and Ser379, respectively (Fig. 3a), were
then used to assess the relative contribution of the two residues to the
ATR-dependent phosphorylation of IBV N protein. H1299 cells were
infected with wild type, Nm3, Nm8 and Nm9mutant viruses, and total
cell lysates were prepared. Western blot analysis of total cell lysates
with antibodies against ATM/ATR substrates showed, once again,
detection of the ATR-dependent phosphorylation of IBV N protein in
cells infected with the virus (Fig. 4b). No obvious phosphorylation of
IBV N protein was detected by the same antiserum in cells infected
with the three mutant viruses (Fig. 4b). These results indicate that
both amino acid residues are phosphorylated by ATR and the
neighboring sequence may affect this ATR-dependent phosphorylation
of IBV N protein.
It was also noted that pChk1 was not readily detected by
Western blot using both ATM/ATR substrate and pChk1-speciﬁc
antibodies under the conditions shown in Fig. 4a and b. The reason
may be due to the relatively low abundance of pChk1, compared to
the phosphorylated N protein in virus-infected cells.Characterization of IBVNm4 mutant virus carrying Ala substitutions
at all the four previously identiﬁed phosphorylation sites on IBV N
protein
The growth properties of IBVNm4 mutant virus were then
characterized. For this purpose, Vero cells in duplicate were
infected with wild type and IBVNm4 at a multiplicity of infection
of approximately 1. At 24 h post-infection, one set of cells was stainedThe effects of Ala substitutions on the ATR-dependent phosphorylation of IBV N
at a multiplicity of infection of approximately 1. The mock-treated cells were also
e subjected to immunoblotting assay. The levels of ATR-dependent phosphorylated
ﬁc antibodies. Tubulin was included as a loading control. (b) Further analysis of the
1299 cells were infected with wild type, Nm3, Nm8 and Nm9 mutant viruses at a
as a control. At 24 h post-infection, cells were harvested and total lysates were
al IBV N were determined with anti-IBV N and anti-ATM/ATR substrates antibodies,
Fig. 5. Further characterization of the Nm4 mutant virus. (a) Immunoﬂuoresent staining of Vero cells infected with wild type and Nm4 mutant virus. Vero cells were
infected with wild type and Nm4 mutant viruses at a multiplicity of infection of approximately 1. At 24 h post-infection, cells were ﬁxed and stained with anti-IBV N
antibodies. (b) Western blot analysis of IBV N protein in cells infected with wild type and IBVNm4 mutant. Vero cells were infected with wild type and Nm4mutant viruses at
a multiplicity of infection of approximately 1. At 24 h post-infection, cells were harvested and total lysates were subjected to immunoblotting assay. The levels of total IBV N
were determined with anti-IBV N antibodies. Tubulin was included as a loading control. (c) Analysis of the growth properties of wild type and Nm4 mutant viruses.
Monolayers of Vero cells on a 6-well plate were infected with 100 μl of 1000-fold diluted virus stock and cultured in the presence of 0.5% carboxymethy cellulose at 37 1C for
3 days. The infected cells were ﬁxed and stained with 0.1% toluidine (upper panels). To determine the growth curves of wild type and mutant IBV, Vero cells were infected
with the viruses and harvested at 0, 4, 8, 16, 24, 36 h post-infection. Viral stocks were prepared by freezing/thawing of the cells three times and TCID50 of each viral stock
was determined by infecting ﬁve wells of Vero cells on 96-well plates in triplicate with 10-fold serial dilution of each viral stock. (d) Analysis of wild type and Nm4 mutant
viruses by ultracentrifugation in a 10–50% sucrose gradient. Vero cells were infected with wild type and Nm4 mutant viruses, at a multiplicity of infection of approximately 1.
At 24 h post-infection, the cultured media were collected and cell debris was removed by centrifugation at 10,000 rpm for 10 min. The virus particles were pelleted through a
20% sucrose cushion. The pellets were resuspended in 1 ml medium and subjected to ultracentrifugation in a 10–50% linear sucrose gradient. Eleven fractions were collected
and the presence of virus particles in each fraction was analyzed by Western blot with antibodies against IBV N protein. The percentage of virus in each fraction was
calculated after determination of the amount of N protein in each fraction by densitometry.
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shown in Fig. 4a, massive syncytium formation was observed in cells
infected with both wild type and mutant viruses. No distinguishable
difference in syncytium formation and subcellular distribution of N
protein between wild type and the mutant viruses was observed
(Fig. 5a). Western blot analysis of another set of the infected cells with
anti-IBV N antibodies showed the presence of both full-length and
other processed forms of the N protein (Li et al., 2005) (Fig. 5b).
Interestingly, slightly more N protein was detected from cells infected
with the mutant virus at this time point (Fig. 5b).
The growth properties of the mutant virus were then studied by
plaque formation and growth kinetics studies. As shown in Fig. 5c,
plaques with similar sizes were found in cells infected with both wild
type and IBVNm4 mutant viruses at 24 h post-infection. Analysis of
the growth kinetics of wild type and the mutant viruses also showed
very similar growth properties for both viruses, although the mutant
virus reached its peak titers at 24 h post-infection, which was 8 h later
than did wild type virus (Fig. 5c). Interestingly, the mutant virus
remained at peak titers until the end of the time course at 32 h post-
infection (Fig. 5c). It is not clear if this may represent an altered cellular
response to the infection caused by this mutant virus.The buoyant density of IBVNm4 mutant virus was then ana-
lyzed by ultracentrifugation using 10–50% sucrose gradients, after
collection of the virus from culture supernatants by spinning down
through a 20% sucrose cushion. Eleven fractions were collected
and analyzed by Western blot with antibodies against IBV N
protein, which was used as a marker for the presence of virus
particles. Both wild type and mutant viral particles were found to
be present mainly in fractions 7 and 8 (50.4% for wild type and
58.4% for IBVNm4) (Fig. 5d). It was noted that more viral particles
(32.0%) were found in fraction 7 for wild type IBV, but more virus
particles (39.2%) were found in fraction 8 for the mutant virus
(Fig. 5d). These results demonstrate that the mutant virus may
have a slightly lower buoyant density than wild type virus. Further
study would be required to conﬁrm if this difference may reﬂect
the difference in the phosphorylation of the N protein.Discussion
Coronavirus N protein plays multiple functions during the viral
replication cycle. Available evidence suggests that most of its
S. Fang et al. / Virology 444 (2013) 225–232230functions may be regulated by the phosphorylation of the protein
(Calvo et al., 2005; Jayaram et al., 2005; Shin et al., 2007; Surjit
et al., 2005; Spencer et al., 2008). In this study, two previously
identiﬁed phosphorylation sites in IBV N protein, Thr378 and
Ser379, are shown to be phosphorylated by ATR, which is activated
by IBV-induced DNA replication stress during IBV infection of cells
(Xu et al., 2011). Ala substitutions of these two residues together
with the other two previously identiﬁed phosphorylation sites
(Ser190 and Ser192) as well as two predicted sites for ATR
individually or in combination did not affect the recovery of
infectious viruses containing the mutations.
In this study, we provided evidence suggesting that phosphor-
ylation of IBV N protein at Thr378 and Ser379 by ATR appears to
play a limited, if any, regulatory function in IBV replication and
infectivity in cultured cells. As IBVNm4 also covers Ala substitu-
tions at other two previously identiﬁed phosphorylation sites
(Ser190Ser192), it would point to the possibility that phosphor-
ylation of coronavirus N protein at these four sites may represent a
by-effect of host response to virus infection. Coronavirus infection
may activate a diversity of host cell signal transduction pathways
as well as kinases, which would in turn lead to the phosphoryla-
tion of viral N protein. This may explain why more phosphorylated
N protein is incorporated into IBV virions (Jayaram et al., 2005), as
extensive phosphorylation of N protein would occur at a relatively
late stage of the viral infection cycle. It is currently unclear if this is
speciﬁc to IBV, as some other coronaviruses, such as MHV, tend to
incorporate hypophosphorylated N protein into virions (White
et al., 2007)
On the other hand, we cannot rule out the possibility that
phosphorylation of IBV N protein may occur at other positions in
cells infected with Nm4 and other related mutant viruses, and
phosphorylation at these alternate sites would functionally com-
pensate for the loss of phosphorylation at these four positions.
This possibility would be supported by the observation that
signiﬁcantly more phosphorylated N protein was detected in cells
infected with Nm5, Nm6 and Nm7 mutant viruses, than in cells
infected with Nm4. It appears that additional Ala substitutions at
Ser65 and Thr109 in these three mutant viruses might induce
more phosphorylation of IBV N protein at a site(s) recognized by
the pChk1-speciﬁc antibodies used. In this context, it would be
interesting to determine which phosphorylation site(s) of IBV N
protein may be recognized by this pChk1-speiﬁc antiserum. Data
present in this study are inconclusive, but appear to indicate that
both Thr378 and Ser379 may be recognized speciﬁcally or non-
speciﬁcally by the pChk1 antibodies used, as signiﬁcantly reduced
amounts of the phosphorylated N protein were detected in cells
infected with mutant viruses containing mutations at these two
positions, compared to that in cells infected with wild type and
other mutants. However, as certain amounts of the phosphory-
lated N protein were still detected by this antiserum in cells
infected with these mutant viruses, other phosphorylation site
(s) must exist.
Multiple cellular kinases are involved in phosphorylation of
coronavirus N protein. This may constitute another layer of
regulatory mechanisms controlling the phosphorylation status of
coronavirus N protein in virus-infected cells. For example, both
Thr378 and Ser379 residues could be phosphorylated by casein
kinase II (CKII), as predicted by computer-aided programs. It was
reported that CKII can be stabilized by ATR-dependent phosphor-
ylation of Chk1 at Ser317 in response to stalled DNA replication
(Martin and Ouchi, 2008). This in turn would lead to phosphoryla-
tion of phosphatase and tensin homolog protein (PTEN) at Thr383.
As IBV infection activates the ATR/Chk1 pathway, phosphorylation
of IBV N protein at multiple sites may be also regulated by a similar
mechanism. In addition, phosphorylation of N protein is most
likely a dynamic process, timely regulated during the infectioncycle. In this study, we showed that the phosphorylated N protein
was detected by a pChk1-speciﬁc antibody at as early as 8 h post-
infection, as well as at 24 h post-infection. Analysis of the effects of
Ala substitutions on the phosphorylation status of IBV N protein in
virus-infected cells was carried out at 24 h post-infection in most
of the studies shown here. This time point was chosen based on
the consideration that slightly delayed growth kinetics was
observed in most of the mutant viruses. It was noted that more
phosphorylated N protein was detected in cells infected with some
mutant viruses (mainly Nm1 and Nm2 mutant viruses) than that
in cells infected with wild type virus. This may reﬂect this dynamic
regulatory process at this time point.
The successful recovery of viruses from all the mutant con-
structs conﬁrms that phosphorylation at these positions is not
essential for the viability of IBV in cultured cells. In fact, Western
blot analysis of viral protein expression and viral growth kinetics
analysis showed that most of the mutant viruses grew similarly
well as wild type virus. This is conﬁrmed by detailed analysis of
the growth properties and kinetics of IBVNm4, showing that the
mutant virus grew equally well, if not better, as wild type virus,
although a slightly delayed growth kinetics was observed. Inter-
estingly, after reaching peak titer at 24 h post-infection, the
mutant virus remains at its peak titer until the end of the time
course at 32 h post-infection. This is in contrast to wild type virus,
which reached the peak titer at 16–24 h post-infection. The titers
were gradually declined afterward. The underlying mechanisms
for this difference are currently unknown, but it may reﬂect the
difference in virus–host interactions between wild type and the
mutant virus. One possibility is that the mutant virus may have an
altered ability to induce cell death or cell cycle arrest. A more
thorough study would be required to understand this issue more.
In conclusion, this study has provided strong evidence that
activation of ATR/Chk1 pathway during IBV infection is responsible
for phosphorylation of IBV N protein at two previously identiﬁed
sites. Phosphorylation of N protein at these two positions, how-
ever, may play limited, if any, regulatory functions in IBV replica-
tion and infectivity in cultured cells. This would meanwhile
reinforce our previous conclusion that IBV infection leads to
efﬁcient activation of the ATR pathway (Xu et al., 2011).Materials and methods
Cells and viruses
Vero (ATCC CCL-81) cells were maintained in DMEM supple-
mented with 10% fetal bovine serum (FBS), penicillin (100 units/
ml) and streptomycin (100 μg/ml) at 37 1C in a 5% CO2 environ-
ment. H1299 (ATCC CRL-5803) cells were maintained in complete
RPMI 1640 medium (JRH) supplemented with 10% newborn calf
serum. Both Vero and H1299 cells were routinely used to culture
Vero-adapted IBV (Liu et al., 1995, 1998; Tay et al., 2012)
The passage 65 (p65, designated wild type virus (wtIBV) of
Vero-adapted IBV Beaudette was described before (Fang et al.,
2005, 2007). The IBV strains were propagated in Vero cells and the
tissue culture infective dose (TCID50) of viral stocks was calculated
by the Reed–Muench method (Yamada and Liu, 2009). Viral stocks
were kept at −80 1C until use.
Chemicals and antibodies
Schisandrin B (SchB, Shanghai TauTo Biotech Co. LTD., China)
was dissolved in DMSO and stored at −80 1C, as previously
described (Xu et al., 2011).
Antibodies against Chk1Ser317 and phospho-(Ser/Thr) ATM/
ATR substrates were purchased from Cell Signaling Technology
S. Fang et al. / Virology 444 (2013) 225–232 231(Beverely, MA, USA). Antibody against Flag was from Sigma-
Aldrich, and antibodies against actin and tubulin were from Santa
Cruz (Santa Cruz, CA). Polyclonal antibodies against IBV N and S
were raised in rabbits (Xu et al., 2010; Yamada and Liu, 2009).
Horseradish peroxidase (HRP)-linked goat anti-rabbit secondary
antibodies, HRP-linked goat anti-mouse secondary antibodies
were purchased from Dako (Glostrup, Denmark).
Drug treatment and Luciferase reporter assay
Inhibitors SchB was added to cells 1 h prior to infection or 8 h
post-transfection, and kept in the media during the infection. Cells
of 90–95% conﬂuency grown on 12-well plates were infected with
IBV at a multiplicity of infectivity of approximately 1, and were
harvested at the indicated time points post-infection.
Plasmid construction and transfection
Plasmid pKT-0 which has T7 promoter for transcription was
used for transient transfection using the vaccinia/T7 recombinant
virus (Ng and Liu, 2000, 2002). The pKT-N construct that encoded
full-length N protein was previously reported (Li et al., 2005).
Epitope-tagged constructs were made by overlap PCR and cloned
into the pKT-0. Point mutations were made by site-directed
mutagenesis using the Quikchange™ kit (Stratagene). Cells at
about 90% conﬂuency were infected with the recombinant vacci-
nia/T7 virus for 1 h followed by transfection of plasmid DNA using
the Effectene Transfection reagent (Qiagen).
Western Blotting (WB)
Each sample was lysed with 1 SDS sample loading buffer
without bromophenol blue and the protein concentration was
determined by the Bio-rad Protein Assay kit. Equal amounts of
total protein were separated by SDS-PAGE and transferred to PVDF
membranes. Membranes were incubated with a primary antibody,
subsequently with HRP-conjugated secondary antibody, and
detected using the ECL Advance Western Blotting Detection Kit
(Amersham).
Immunoﬂuorescent (IF) staining
Vero cells were cultivated in 4-well chamber slides (Iwaki).
IBV-infected cells were washed with phosphate buffered saline
(PBS) supplemented with 10% normal goat serum, ﬁxed with 4%
paraformaldehyde in PBS for 15 min, and permeabilized with 0.2%
Triton X-100 for 10 min. IF staining was performed by incubating
cells with polyclonal antibodies against IBV N protein and subse-
quently with the FITC-conjugated anti-rabbit IgG. Cells were
examined by ﬂuorescent microscopy.
Construction of mutant IBV by in vitro transcription of full-length
wild type or mutant IBV cDNA and electroporation
The detailed procedure to create a full-length IBV cDNA clone
was previously reported (Tan et al., 2006; Fang et al., 2007).
The region of the IBV cDNA covering the N gene was replaced
with mutant N genes, and subsequently ligated into full-length IBV
cDNA. Full-length transcripts were generated in vitro using the
mMessage mMachine T7 kit (Ambion, Austin, Tex). Wild type IBV
N gene transcripts were also generated to enhance the recovery of
virus. Vero cells at about 90% conﬂuency were trypsinized, washed
twice with ice-cold PBS, and resuspended in PBS. RNA transcripts
were introduced into Vero cell by using the Bio-Rad Gene Pulser II
electroporator. Cells were cultured overnight in 1% FBS-containing
DMEM in a 6-well plate and further incubated in DMEM withoutFBS. At 48 h post-electroporation, viral RNA replication was
investigated by RT-PCR of the negative strand gRNA. Transcription
of subgenomic mRNAs was investigated by RT-PCR as described
before (Tan et al., 2006; Fang et al., 2007). The N gene of recovered
rIBV clones (at the 3rd passage in Vero cells) was ampliﬁed by RT-
PCR and subsequently conﬁrmed by the DNA sequencing analysis.
Characterization was carried out with the 3rd passage of viruses in
Vero cells.
Densitometry
The intensities of RNA and protein bands were quantiﬁed using
ImageJ program according to the manufacturer's instruction.Acknowledgement
This work was partially supported by a Competitive Research
Programme (CRP) grant (R-154-000-529-281), the National Research
Foundation, Singapore.
References
Almazán, F., Galán, C., Enjuanes, L., 2004. The nucleoprotein is required for efﬁcient
coronavirus genome replication. J. Virol. 78, 12683–12688.
Baric, R.S., Nelson, G.W., Fleming, J.O., Deans, R.J., Keck, J.G., Casteel, N., Stohlman, S.A.,
1988. Interactions between coronavirus nucleocapsid protein and viral RNAs:
implications for viral transcription. J. Virol. 62, 4280–4287.
Calvo, E., Escors, D., López, J.A., González, J.M., Alvarez, A., Arza, E., Enjuanes, L.,
2005. Phosphorylation and subcellular localization of transmissible gastroen-
teritis virus nucleocapsid protein in infected cells. J. Gen. Virol. 86, 2255–2267.
Cavanagh, D., 2007. Coronavirus avian infectious bronchitis virus. Vet. Res. 38,
281–297.
Chang, C.K., Hsu, Y.L., Chang, Y.H., Chao, F.A., Wu, M.C., Huang, Y.S., Hu, C.K., Huang,
T.H., 2009. Multiple nucleic acid binding sites and intrinsic disorder of severe
acute respiratory syndrome coronavirus nucleocapsid protein: implications for
ribonucleocapsid protein packaging. J. Virol. 83, 2255–2264.
Chang, R.Y., Brian, D.A., 1996. cis requirement for N-speciﬁc protein sequence in
bovine coronavirus defective interfering RNA replication. J. Virol. 70,
2210–2217.
Chen, H., Gill, A., Dove, B.K., Emmett, S.R., Kemp, C.F., Ritchie, M.A., Dee, M., Hiscox,
J.A., 2005. Mass spectroscopic characterization of the coronavirus infectious
bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in
RNA binding by using surface plasmon resonance. J. Virol. 79 (2), 1164–1179.
Chen, H., Wurm, T., Britton, P., Brooks, G., Hiscox, J.A., 2002. Interaction of the
coronavirus nucleocapsid with nucleolar antigens and the host cell. J. Virol. 76,
5233–5250.
Davies, H.A., Dourmashkin, R.R., MacNaughton, R., 1981. Ribonucleoprotein of avian
infectious bronchitis virus. J. Gen. Virol. 53, 67–74.
Escors, D., Ortego, J., Laude, H., Enjuanes, L., 2001. The membrane M protein
carboxy terminus binds to transmissible gastroenteritis coronavirus core and
contributes to core stability. J. Virol. 75, 1312–1324.
Fan, H., Ooi, A., Tan, Y.W., Wang, S., Fang, S.G., Liu, D.X., Lescar., J., 2005. Crystal
structure of the N-terminal domain from the nucleocapsid protein of corona-
virus infectious bronchitis virus. Structure 13, 1859–1868.
Fang, S., Shen, H., Wang, J., Tay, F.P., Liu, D.X., 2010. Functional and genetic studies of
the substrate speciﬁcity of coronavirus infectious bronchitis virus 3C-like
proteinase. J. Virol. 84, 7325–7336.
Fang, S.G., Shen, H., Wang, J., Tay, F.P., Liu, D.X., 2008. Proteolytic processing of
polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of
Coronavirus infectious bronchitis virus is dispensable for viral replication in
cultured cells. Virology 379, 175–180.
Fang, S.G., Chen, B., Tay, F.P., Ng, B.S., Liu., D.X., 2007. An arginine-to-proline
mutation in a domain with undeﬁned functions within the helicase protein
(Nsp13) is lethal to the coronavirus infectious bronchitis virus in cultured cells.
Virology 358, 136–147.
Fang, S.G., Shen, S., Tay, F.P., Liu., D.X., 2005. Selection of and recombination
between minor variants lead to the adaptation of an avian coronavirus to
primate cells. Biochem. Biophys. Res. Commun. 336, 417–423.
Hiscox, J.A., Wurm, T., Wilson, L., Cavanagh, D., Britton, P., Brooks, G., 2001. The
coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus.
J. Virol. 75, 506–512.
Jayaram, J., Youn, S., Collisson, E.W., 2005. The virion N protein of infectious
bronchitis virus is more phosphorylated than the N protein from infected cell
lysates. Virology 339, 127–135.
Kim, T.W., Lee, J.H., Hung, C.F., Peng, S., Roden, R., Wang, M.C., Viscidi, R., Tsai, Y.C.,
He, L., Chen, P.P., Boyd, D.A.K., Wu, T.C., 2004. Generation and characterization
of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory
syndrome coronavirus. J. Virol. 78, 4638–4645.
S. Fang et al. / Virology 444 (2013) 225–232232Lai, M.M., Cavanagh, D., 1997. The molecular biology of coronaviruses. Adv. Virus
Res. 48, 1–100.
Li, F.Q., Xiao, H., Tam, J.P., Liu, D.X., 2005. Sumoylation of the nucleocapsid protein of
severe acute respiratory syndrome associated coronavirus. FEBS Lett. 579,
2387–2396.
Li, Q., Tam, J.P., Liu., D.X., 2007. Cell cycle arrest and apoptosis induced by the
coronavirus infectious bronchitis virus in the absence of p53. Virology 365,
435–445.
Liu, D.X., Tibbles, K.W., Cavanagh, D., Brown, T.D., Brierley, I., 1995. Identiﬁcation,
expression, and processing of an 87-kDa polypeptide encoded by ORF 1a of the
coronavirus infectious bronchitis virus. Virology 208, 48–57.
Liu, D.X., Shen, S., Xu, H.Y., Wang, S.F., 1998. Proteolytic mapping of the coronavirus
infectious bronchitis virus 1b polyprotein: evidence for the presence of four
cleavage sites of the 3C-like proteinase and identiﬁcation of two novel cleavage
products. Virology 246, 288–297.
Martin, S.A., Ouchi, T., 2008. Cellular commitment to reentry into the cell cycle after
stalled DNA is determined by site-speciﬁc phosphorylation of Chk1 and PTEN.
Mol. Cancer Ther. 7, 2509–2516.
Narayana, K., Maeda, A., Maeda, J., Makina, S., 2000. Characterization of the
coronavirus M protein and nuclocapsid interaction in infected cells. J. Virol.
74, 8127–8134.
Ng, L.F.P., Liu, D.X., 2000. Further characterization of the coronavirus infectious
bronchitis virus 3C-like proteinase and determination of a new cleavage site.
Virology 272, 27–39.
Ng, L.F., Liu, D.X., 2002. Membrane association and dimerization of a cysteine-rich,
16-kilodalton polypeptide released from the C-terminal region of the corona-
virus infectious bronchitis virus 1a polyprotein. J. Virol. 76, 6257–6267.
Riso, C., Anton, I.M., Enjuanes, L., Carrascosa, J.L., 1996. The transmissible gastro-
enteritis coronavirus contains a spherical core shell consisting of M and N
proteins. J. Virol. 70, 4773–4777.
Shin, G.C., Chung, Y.S., Kim, I.S., Cho, H.W., Kang, C., 2007. Antigenic characterization
of severe acute respiratory syndrome-coronavirus nucleocapsid protein
expressed in insect cells: the effect of phosphorylation on immunoreactivity
and speciﬁcity. Virus Res. 127 (1), 71–80.
Snijder, E.J., Bredenbeek, P.J., Dobbe, J.C., Thiel, V., Ziebuhr, J., Poon, L.L.M., Guan, Y.,
Rozanov, M., Spaan, W.J.M., Gorbalenya, A.E., 2003. Unique and Conserved
features of genome and proteome of SARS-coronavirus, an early split-off from
the coronavirus group 2 lineage. J. Mol. Biol. 331, 991–1004.
Spencer, K.A., Dee, M., Britton, P., Hiscox, J.A., 2008. Role of phosphorylation clusters
in the biology of the coronavirus infectious bronchitis virus nucleocapsid
protein. Virology 370 (2), 373–381.
Stohlman, S.A., Baric, R.S., Nelson, G.W., Soe, L.H., Welter, L.M., Deans, R.J., 1988.
Speciﬁc interaction between coronavirus leader RNA and nucleocapsid protein.
J. Virol. 62, 4288–4295.
Surjit, M., Kumar, R., Mishra, R.N., Reddy, M.K., Chow, V.T., Lal, S.K., 2005. The severe
acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylatedand localizes in the cytoplasm by 14-3-3-mediated translocation. J. Virol. 79 (17),
11476–11486.
Tahara, S.M., Dietlin, T.A, Bergmann, C.C., Nelson, G.W., Kyuwa, S., Anthony, R.P.,
Stohlman, S.A., 1994. Coronavirus translational regulation: leader affects mRNA
efﬁciency. Virology 202, 621–630.
Tan, Y.W., Fang, S.G., Fan, H., Lescar, J., Liu., D.X., 2006. Amino acid residues critical
for RNA-binding in the N-terminal domain of the nucleocapsid protein are
essential determinants for the replication and infectivity of coronavirus in
cultured cells. Nucleic Acids Res. 34, 4816–4825.
Tan, Y.W., Hong, W., Liu., D.X., 2012. Binding of the 5′-untranslated region of
coronavirus RNA to zinc ﬁnger CCHC-type and RNA binding motif 1 enhances
viral replication and transcription. Nucleic Acids Res. 40, 5065–5077.
Thiel, V., Ivanov, K.A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., Weissbrich, B.,
Snijder, E.J., Rabenau, H., Doerr, H.W., Gorbalenya, A.E., Ziebuhr, J., 2003.
Mechanisms and enzymes involved in SARS coronavirus genome expression.
J. Gen. Virol. 84, 2305–2315.
Tay, F.P., Huang, M., Wang, L., Yamada, Y., Liu, D.X., 2012. Characterization of cellular
furin content as a potential factor determining the susceptibility of cultured
human and animal cells to coronavirus infectious bronchitis virus infection.
Virology 433, 421–430.
White, T.C., Yi, Z., Hogue, B.G., 2007. Identiﬁcation of mouse hepatitis coronavirus
A59 nucleocapsid protein phosphorylation sites. Virus Res. 126 (1–2), 139–148.
Wilson, V.G., Rangasamy, D., 2001. Viral interaction with the host cell sumoylation
system. Virus Res. 81, 17–27.
Wu, C.H., Yeh, S.H., Tsay, Y.G., Shieh, Y.H., Kao, C.L., Chen, Y.S., Wang, S.H., Kuo, T.J.,
Chen, D.S., Chen, P.J., 2009. Glycogen synthase kinase-3 regulates the phos-
phorylation of severe acute respiratory syndrome coronavirus nucleocapsid
protein and viral replication. J. Biol. Chem. 284, 5229–5239.
Wurm, T., Chen, H., Britton, P., Brooks, G., Hiscox, J.A., 2001. Localization to the
nucleolus is a common feature of coronavirus nucleoproteins and the protein
may disrupt host cell division. J. Virol. 75, 9345–9356.
Xu, L.H., Huang, M., Fang, S.G., Liu., D.X., 2011. Coronavirus Infection Induces DNA
replication stress partly through interaction of its nonstructural protein 13 with
the p125 subunit of DNA polymerase delta. J. Biol. Chem. 286, 39546–39559.
Xu, L.H., Khadijah, S., Fang, S.G., Wang, L., Tay, F.P.L., Liu., D.X., 2010. The cellular RNA
helicase DDX1 interacts with coronavirus nonstructural protein 14 and
enhances viral replication. J. Virol. 84, 8571–8583.
Yamada, Y., Liu, D.X., 2009. Proteolytic activation of the spike protein at a novel
RRRR/S motif is implicated in furin-dependent entry, syncytium formation and
infectivity of coronavirus infectious bronchitis virus in cultured cells. J. Virol.
83, 8744–8758.
Zhou, M., Williams, A.K., Chung, S.I., Wang, L., Collisson, E.W., 1996. The infectious
bronchitis virus nucleocapsid protein binds RNA sequences in the 3′ terminus
of the genome. Virology 217, 191–199.
Zúñiga, S., Cruz, J.L., Sola, I., Mateos-Gómez, P.A., Palacio, L., Enjuanes, L., 2010.
Coronavirus nucleocapsid protein facilitates template switching and is required
for efﬁcient transcription. J. Virol. 84, 2169–2175.
